This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response.
Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global average price of Prostaglandin is in the decreasing trend, from 361.6 USD/Kg in 2012 to 331.1 USD/L in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Prostaglandin includes Human Prostaglandin and Veterinary Prostaglandin. The proportion of Human Prostaglandin in 2016 is about 82%, and the proportion is in decreasing trend from 2012 to 2016.
Prostaglandin is widely used in Cardiovascular, Digestive, Gynecological and Obstetrical, Ophthalmologic, etc. The most proportion of Prostaglandin is Cardiovascular, and the sales in 2016 is about 410 Kg.
According to this study, over the next five years the Prostaglandin market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 660 million by 2024, from US$ 460 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostaglandin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostaglandin market by product type, application, key manufacturers and key regions and countries.
This study considers the Prostaglandin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Human Prostaglandin
Veterinary Prostaglandin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Cardiovascular
Digestive
Gynecological and Obstetrical
Ophthalmologic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CEPIA
Johnson Matthey
Pfizer
Cayman Chemical
EMD Millipore
Yonsung Fine Chemicals
Everlight Chemical
Piramal Enterprises
Bio-Techne Corporation
Mironova Labs
Chirogate
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostaglandin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Prostaglandin market by identifying its various subsegments.
Focuses on the key global Prostaglandin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostaglandin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostaglandin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
